R&D Manufacturing key to overcoming the next pandemic Ben Hargreaves looks at the way governments are preparing for a future pandemic.
R&D Improving treatment for high-risk cataract surgery Cataracts rank among the most prevalent age-related ailments.
Market Access Unlocking superpower status: The crucial role of space in sc... There has been a lot of hype around the government's plan to
R&D A new approach to drug design: Restoring the effectiveness o... None of us are unaware of the very real danger of ‘superbugs’ – only last month, the hospita
R&D Strong solutions for increasing dermatology research diversi... As a woman of colour, I am very careful about the skin care products I use. I must be.
R&D Alzheimer’s drugs: An overview and update When we covered JP Morgan in January, over and over we heard that neurodegenerative diseases, especially Alzheimer’s, were going to be one of the most exciting spaces in pharma this year.
News MSD gets first FDA okay for oral PCSK9 cholesterol drug MSD has won the race to bring an oral PCSK9 inhibitor through to regulatory approval for LDL cholesterol-lowering in the US.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
